NUVB Nuvation Bio Inc.

NYSE
$6.07

Nuvation Bio Inc. (NUVB) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with NUVB's own trailing one-year pace, with 41% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
6
17 transactions
Purchases
$118.3K
25,000 shares
Sales
$9.7M
1,511,469 shares
Net activity
-$9.6M
purchases less sales

How much of that selling was preplanned? 41% planned / 59% discretionary

10b5-1 plan sales $4.0M 8 transactions · 722,418 shares
Discretionary sales $5.7M 9 transactions · 789,051 shares

Largest single sale: $2.2M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 9, 2026 , by Mashal Robert .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Hattersley Gary CHIEF SCIENTIFIC OFFICER Sell 10b5-1 100,000 $7.09 $709.2K None left
Markel Stacy CHIEF PEOPLE OFFICER Sell 10b5-1 125,000 $6.03 $753.2K 32,591 −79.3% of holding
Wentworth Kerry CHIEF REGULATORY OFFICER Sell 10b5-1 63,000 $6.02 $379.2K 53,000 −54.3% of holding
Sauvage Philippe Chief Financial Officer Sell 10b5-1 47,668 $6.01 $286.4K 12,673 −79% of holding
Mashal Robert Director Buy 25,000 $4.73 $118.3K 225,000
Liu Dongfang CHIEF MEDICAL OFFICER Sell 10b5-1 50,000 $5.02 $251.0K 18,000 −73.5% of holding
Wentworth Kerry CHIEF REGULATORY OFFICER Sell 10b5-1 36,750 $5.01 $184.3K 53,000 −40.9% of holding
Wentworth Kerry CHIEF REGULATORY OFFICER Sell 10b5-1 200,000 $4.52 $903.6K 53,000 −79.1% of holding
Liu Dongfang CHIEF MEDICAL OFFICER Sell 150,000 $7.82 $1.2M 18,000 −89.3% of holding
Liu Dongfang CHIEF MEDICAL OFFICER Sell 10,000 $8.00 $80.0K 18,000 −35.7% of holding
Liu Dongfang CHIEF MEDICAL OFFICER Sell 10,000 $7.50 $75.0K 18,000 −35.7% of holding
Hattersley Gary 2 fills CHIEF SCIENTIFIC OFFICER Sell 369,051 $7.23 $2.7M None left
Liu Dongfang CHIEF MEDICAL OFFICER Sell 20,000 $7.00 $140.1K 18,000 −52.6% of holding
Hanley David C. CHIEF TECHNICAL OPERATIONS Sell 200,000 $7.14 $1.4M 24,000 −89.3% of holding
Liu Dongfang CHIEF MEDICAL OFFICER Sell 15,000 $5.10 $76.6K 18,000 −45.5% of holding
Liu Dongfang CHIEF MEDICAL OFFICER Sell 15,000 $4.76 $71.5K 15,000 −50% of holding
Hattersley Gary CHIEF SCIENTIFIC OFFICER Sell 10b5-1 100,000 $5.02 $502.5K None left

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.